Next, to investigate the effect of the APJ antagonist on pathological retinal angiogenesis in ischemic retinopathy, we employed the OIR model, which is a widely used system to examine ocular neovascularization, a condition that resembles proliferative diabetic retinopathy in humans20. The gene discussed is APLNR; the disease is proliferative diabetic retinopathy.